Drug intelligence / Profile preview

Jinbei oral liquid

Development stage
Unknown
Lead developer
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Jinbei oral liquid is a Traditional Chinese Medicine (TCM) formulation developed by Shandong Provincial Hospital for the treatment of idiopathic pulmonary fibrosis (IPF). As a botanical-based therapy, it is hypothesized to exert multi-target effects, including the inhibition of inflammatory responses and the modulation of pro-fibrotic signaling pathways, thereby reducing lung tissue scarring and improving respiratory function. It is typically administered as an oral solution and has been evaluated in multicenter, randomized, double-blind clinical trials to establish its efficacy and safety profile as a therapeutic option for patients with IPF.

Brand names
Jinbei oral liquid
Other names
JinbeiJinbei Koufuye金贝口服液
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))AGER (RAGE)

Beyond the preview

Go deeper on Jinbei oral liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinbei oral liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call